Maternal atopic disease modifies effects of prenatal risk factors on exhaled nitric oxide in infants.
about
Effect of intubation and mechanical ventilation on exhaled nitric oxide in preterm infants with and without bronchopulmonary dysplasia measured at a median postmenstrual age of 49 weeksExpired nitric oxide and airway reactivity in infants at risk for asthma.Lung function in African infants: a pilot studyA strong synergism of low birth weight and prenatal smoking on asthma in schoolchildren.Sex differences in factors associated with childhood- and adolescent-onset wheeze.Asthma: epidemiology, etiology and risk factors.Epidemiology of asthma: risk factors for development.Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications.Elevated exhaled nitric oxide in newborns of atopic mothers precedes respiratory symptoms.Exhaled Nitric Oxide in Acute Phase of Bronchiolitis and Its Relation with Episodes of Subsequent Wheezing in Children of Preschool Age.Cystic fibrosis, pediatrics, control of breathing, pulmonary physiology and anatomy, and surfactant biology in AJRCCM in 2004.Exhaled nitric oxide in symptomatic children at preschool age predicts later asthma.DENND1B gene variants associate with elevated exhaled nitric oxide in healthy high-risk neonatesElevated Exhaled Nitric Oxide in High-Risk Neonates Precedes Transient Early but Not Persistent WheezeMaternal Tobacco Smoking and Decreased Leukocytes, Including Dendritic Cells, in Neonates
P2860
Q33915722-2EEDFCDE-A56C-49A9-B351-10AE347F9306Q35019056-C663FED2-257A-4B7E-B1F0-EA2C16841CEAQ35034601-B6B8D2E7-4D83-4B91-8E70-2FB316DA3B67Q36071177-EC56152D-D86D-4C0D-97B5-E0C5FCFFFF52Q37282721-198A899E-DEB4-4602-84E6-671D2E203283Q37394081-B6EB2249-C01E-44D7-9F57-1204FB885CC9Q37754512-ED9FF422-094D-4352-AA08-107FCE11C855Q39951779-713B3883-832B-484C-ACF6-09EA0768AF40Q40288250-20D9C844-BD99-4359-BAC1-C99F196B117AQ41826945-FC4DC1D8-6AF4-4D50-A6F0-2A3381002087Q47836713-E6A917BB-289F-4CA1-9582-DD08089A01D1Q50871206-71B1E8EE-57A1-4880-A06C-2D1DCFE783A6Q57638045-C510857B-7BB3-47D2-94A3-0E59846FE8A8Q57638145-730D9852-2130-4271-8550-D9151AAF41F6Q57661245-7C3E85C8-DA21-4DF6-A60A-45E5A00775CC
P2860
Maternal atopic disease modifies effects of prenatal risk factors on exhaled nitric oxide in infants.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Maternal atopic disease modifi ...... haled nitric oxide in infants.
@en
Maternal atopic disease modifi ...... haled nitric oxide in infants.
@nl
type
label
Maternal atopic disease modifi ...... haled nitric oxide in infants.
@en
Maternal atopic disease modifi ...... haled nitric oxide in infants.
@nl
prefLabel
Maternal atopic disease modifi ...... haled nitric oxide in infants.
@en
Maternal atopic disease modifi ...... haled nitric oxide in infants.
@nl
P2093
P2860
P1476
Maternal atopic disease modifi ...... xhaled nitric oxide in infants
@en
P2093
Benjamin Reinmann
Hanna Roiha
Johannes H Wildhaber
Mateja Cernelc
P2860
P304
P356
10.1164/RCCM.200307-1002OC
P407
P577
2004-04-01T00:00:00Z